# #137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

**Channel:** Peter Attia MD
**Upload Date:** 2020-11-16
**URL:** https://www.youtube.com/watch?v=CZJYoi_VIic
**Duration:** 96 minutes

## Description

Paul Offit is a pediatrician specializing in infectious diseases and an expert in virology and vaccine development. He currently serves on the FDA committee overseeing and evaluating COVID-19 vaccines. In this episode, Paul discusses the strategies and major companies pursuing a vaccine against the SARS-CoV-2 virus. He gets into the nuances of the vaccine approval process and its implications for COVID-19 vaccine outlook. Paul also explains potential risks, reveals his own confidence level in safety, and gives insight into protection against reinfection with vaccination. Please note that this episode was recorded 11/05/2020, prior to the 11/09/2020 news release of the Pfizer vaccine update.

We discuss:
00:00:00 - Intro
00:03:30 - How Paul’s experience as a child in a chronic care hospital as child informed his path in pediatrics and vaccine development 
00:08:00 - Addressing the anti-vaccination sentiment and explaining the fraudulent origins of the anti-vaccination movement 
00:17:00 - Lessons and insights from 26 years studying rotavirus and creating a successful rotavirus vaccine 
00:27:15 - Developing a new vaccine: the different phases of clinical trials, overall timeline, and financial costs 
00:32:30 - Operation Warp Speed: the expedited process of creating a coronavirus vaccine 
00:35:00 - Various vaccine strategies—RNA, DNA, virus vector—and the challenges associated 
00:41:15 - The Moderna and Pfizer mRNA vaccines: strategy, timeline, and Emergency Use Authorization 
00:48:30 - Paul’s confidence level in the safety of the first coronavirus vaccines  
00:52:15 - The risks associated with different types of vaccines, and updates on the Johnson & Johnson and Astrazeneca coronavirus vaccines  
00:55:45 - What we know about the coronavirus vaccines approved in Russia and China 
00:57:15 - The latest on the Merck coronavirus vaccine 
00:57:45 - The recombinant/purified protein vaccine approach for coronavirus—big players, risks, and the best vaccine for the elderly 
01:02:00 - Attenuated and inactivated vaccine strategies for coronavirus 
01:02:30 - The genetic drift of SARS-CoV-2: Impacts for protection and vaccine development 
01:06:45 - Paul’s take on the hypothesis that a previous coronavirus infection offers protection against the novel COVID-19 
01:19:15 - Addressing the concern that antibodies fade over time  
01:13:00 - Blood type and protective against coronavirus  
01:13:15 - Distribution: the challenge of prioritizing the limited doses of vaccines after approval 
01:16:15 - Paul’s perspective on COVID-19 vaccine safety  
01:21:45 - Considerations regarding vaccinating children for coronavirus and the role of a fever immune response  
01:29 :45 - Why vaccine development can be challenging and risks of current COVID-19 strategies 

Show notes page: https://peterattiamd.com/pauloffit/

About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com/
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Play: http://bit.ly/TheDriveGooglePlay

## AI Summary

Here's my comprehensive analysis of this episode of The Drive podcast:

1. **Executive Summary**:
This episode features Dr. Paul Offit, a pediatrician and vaccine expert, discussing COVID-19 vaccines and vaccine development in general. The conversation covers the four main strategies for COVID-19 vaccine development, safety considerations, and implementation challenges. Dr. Offit provides historical context from his experience developing the rotavirus vaccine and discusses the unprecedented speed of COVID-19 vaccine development.

2. **Key Medical/Scientific Points**:
- Four main COVID-19 vaccine strategies discussed:
  * mRNA vaccines (Moderna, Pfizer) [00:45:00]
  * Viral vector vaccines (J&J, AstraZeneca) [00:52:00]
  * Protein-based vaccines (Novavax, Sanofi) [01:00:00]
  * Inactivated/attenuated vaccines (Chinese candidates) [01:05:00]

- Vaccine trial phases explained:
  * Phase 1: 20-100 people, dose-ranging [00:38:00]
  * Phase 2: Hundreds of people, immune response [00:40:00]
  * Phase 3: Tens of thousands, efficacy [00:42:00]

3. **Health Optimization Tips**:
Universal recommendations:
- Don't suppress fever unless medically necessary, as it helps immune response [01:25:00]
- Consider waiting for post-market surveillance data before getting new vaccines [01:15:00]

4. **Notable Quotes**:
"I never breathe a sigh of relief until the first three million doses are out there" - Maurice Hilleman [01:18:30]

5. **Follow-up Questions**:
1. Long-term efficacy of COVID-19 vaccines
2. Impact of genetic drift on vaccine effectiveness
3. Optimal vaccination strategy for children
4. Distribution logistics for different vaccine types

Would you like me to expand on any particular section or provide additional analysis of specific topics discussed in the episode?
